By Kyle Stephenson, Veeva Systems, Inc.
The adoption of purpose-built eTMF applications has quadrupled since 2014. The move from paper to digital has fueled positive change in the industry, enabling organizations to manage their trial master files (TMF) more actively and optimize their processes. The gains don’t have to end there, though.
The latest innovations in eTMF technology, including artificial intelligence (AI) tools, are advancing how the industry works and enabling strategic process improvements.
Across clinical operations, AI is used to match patients to studies more quickly and speed drug development, and it can be similarly applied to eTMF. Here’s what you need to know about AI and how it can transform TMF operations.